Sign in

NCT07022158Completed

Antenatal Body Shape Index and Pregnancy Complications

Relationship Between Antenatal Body Shape Index and Pregnancy Complications

Source: ClinicalTrials.gov · Last updated 15 Jun 2025

Brief summary (registry, in English)

Background/aim: Gestational diabetes (GDM), gestational hypertension (GHT) and preeclampsia are common complications of pregnancy. In this study, it was aimed to determine the relationship between body shape index (ABSI), calculated based on antenatal measurements of the height, weight and waist circumference, and GDM, GHT and preeclampsia. Materials and methods: 170 patients at 6-16th weeks of gestation were prospectively analyzed. Body mass index (BMI) and ABSI were calculated. Patients were analyzed according to the presence of GDM, GHT and preeclampsia at follow-up. Our study is the first in terms of its subject and makes a significant contribution to the literature.

Status (registry)
Completed
Study type
Observational
Enrollment
170 (actual)
First submitted
23 May 2025
Start date
1 Sept 2023
Primary completion date
1 Mar 2024
Lead sponsor
Abant Izzet Baysal University
NCT number
NCT07022158

What you commit to

  • Study type: Observational
  • Participants enrolled: 170
  • From 1 Sept 2023 to the primary completion date, 1 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of Gestational Diabetes, Gestational Hypertension and Preeclampsia in previous pregnancies

Other illness

  • Additional systemic and chronic diseases (chronic hypertension, DM, hepatic diseases such as cholestasis, cardiac diseases, rheumatic diseases, renal diseases…)

Other

  • Multiple pregnancies

Who the study is looking for

  • Having a singleton pregnancy
  • Pregnancy follow-up and birth must have taken place at Bolu Abant İzzet Baysal University Training and Research Hospital.
  • Voluntary informed consent form must be signed to participate in the study.

Age in the registry: 18 years to 43 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Abant Izzet Baysal University Faculty of Medicine, 14030, Bolu, Turkey
Coordinator of this site? Confirm its status
BoluTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.